The University of Miami recently celebrated the groundbreaking of the TCRB. Set to open in 2024, the building will transform the university’s research portfolio to attract and retain leading cancer researchers and experts to South Florida.
“This premier center will drive translational cancer research and foster clinical excellence,” said Chirag Mistry, HOK’s Regional Leader of Science + Technology in Atlanta. “We are thrilled to collaborate with the University of Miami to support scientific discoveries in cancer care through the TCRB.”
The 244,000-square-foot, 12-story building will include spaces for experimental, computational, and clinical research, diagnostic imaging, and clinical care. Eight floors will focus on new and emerging therapies and treatments to cure cancer through collaborative research. Flexible laboratories will feature the latest technologies and equipment to support researchers.
Patients will receive holistic, personalized care based on their specific diagnosis with a goal to improve quality of life and prevent cancer reoccurrences.
The TCRB will be South Florida’s only cancer center designated by the National Cancer Institute. Located in one of the most diverse populations in the U.S., it will promote health equity and reduce racial, ethnic, cultural, and other disparities in cancer care.